ADAM BEATTY: Open Payments
NPI 1962979914 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 52 payments from 14 companies in 2025. Trend: 2023 $69 · 2024 $899 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $177 |
| GlaxoSmithKline, LLC. | 10 | $167 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Optinose US, Inc. | 3 | $154 |
| Amgen Inc. | 4 | $86 |
| GENZYME CORPORATION | 3 | $64 |
| Verona Pharma, Inc. | 1 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| CSL Behring | 3 | $50 |
| Grifols USA, LLC | 2 | $43 |
Products named: DUPIXENT, Xhance, NUCALA, TEZSPIRE, FASENRA, Ohtuvayre, TRELEGY ELLIPTA, Xembify.
Industry payments across PA — which companies pay providers there.
